Page 5 - Swedish (OMX) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED Nov 23, 2024

Explore the Swedish (OMX) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

116 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

AROC

AroCell
SEK 0.41-8.1%-7.9%SEK 93.5mn/aPS1.8xE25.6%n/a

FLUO

FluoGuide
SEK 34.25-1.7%-53.2%SEK 466.1mSEK 133.73PS247xE49.9%n/a

XBRANE

Xbrane Biopharma
SEK 0.19-2.7%-98.8%SEK 294.6mn/aPS1.5xE130.2%n/a

CANTA

Cantargia
SEK 1.81-2.4%-51.5%SEK 332.8mSEK 8.33PB6.8xE-3.4%n/a

LIPUM

Lipum
SEK 16.70-2.3%99.8%SEK 354.2mSEK 15.00PS6683.9xE-22.2%n/a

ISOFOL

Isofol Medical
SEK 2.94-1.8%286.3%SEK 474.9mn/aPB5.2xn/an/a

HAMLET B

Hamlet BioPharma
SEK 2.62-2.2%85.2%SEK 439.5mn/aPB8.1xn/an/a

DMYD B

Diamyd Medical
SEK 12.60-0.8%75.0%SEK 1.3bSEK 40.00PS10088.5xE-10.3%n/a

KDEV

Karolinska Development
SEK 1.04-3.9%-42.7%SEK 281.2mSEK 2.40PS149.7xE5.8%n/a

INIT

Initiator Pharma
SEK 6.45-3.0%-31.2%SEK 362.8mSEK 22.47PB12.4xE-40.0%n/a

PROB

Probi
SEK 350.00-0.3%65.1%SEK 4.0bn/aPE366.4xE62.0%0.4%

CURAS

Curasight
DKK 10.90-5.2%-39.3%DKK 225.4mDKK 27.00PB16.9xS105.6%n/a

PRO

Promimic
SEK 27.80-2.8%-20.8%SEK 518.7mn/aPS11.5xn/an/a

ATORX

Alligator Bioscience
SEK 0.53-4.9%27.1%SEK 399.5mSEK 2.00PS14.4xE35.0%n/a

EGTX

Egetis Therapeutics
SEK 5.34-1.1%-3.1%SEK 1.9bSEK 10.80PS28.3xE106.4%n/a

MAGLE

Magle Chemoswed Holding
SEK 32.60-4.1%37.0%SEK 599.9mSEK 50.00PE35.8xS27.0%n/a

DVYSR

Devyser Diagnostics
SEK 129.00-1.9%76.7%SEK 2.1bSEK 158.18PS10.8xE119.5%n/a

MOB

Moberg Pharma
SEK 18.26-4.8%77.3%SEK 852.6mSEK 19.00PS97.1xE66.5%n/a

BINV

BioInvent International
SEK 44.55-2.6%189.3%SEK 2.9bSEK 90.00PS75.9xE108.6%n/a

SOBI

Swedish Orphan Biovitrum
SEK 290.00-0.2%14.5%SEK 99.6bSEK 360.36PE28.3xE20.2%n/a
Page 5 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.